Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Front Immunol. 2022 Jul 28;13:897781. doi: 10.3389/fimmu.2022.897781. eCollection 2022.
infection is generally asymptomatic as latent tuberculosis, but it is still known as the world's leading bacterial cause of death. The diagnosis of latent tuberculosis infection relies on the evidence of cellular immunity to mycobacterial antigens. Since the association between HLA class II and tuberculosis infection has been reported in several population groups, a detailed study on the CD4 T cell response to major tuberculosis antigens is needed. To elucidate which HLA class II allotypes in an individual are preferentially used in tuberculosis, CD4 T cells specific to TB10.4, Ag85b, ESAT-6, and CFP-10 of antigens were analyzed comprehensively. A total of 33 healthy donors were analyzed by and cultured ELISPOT using panels of artificial antigen-presenting cells expressing a single HLA class II allotype. The CD4 T cell responses were increased by an average of 39-fold in cultured ELISPOT compared with ELISPOT. In and cultured ELISPOT, CD4 T cell responses showed significantly higher by HLA-DR than those of HLA-DQ and HLA-DP locus. In cultured ELISPOT, 9 HLA-DR allotypes, 4 HLA-DQ allotypes, and 3 HLA-DP allotypes showed positive CD4 T cell responses. Among ten donors with positive CD4 T cell responses when tested for mixed Mycobacterium tuberculosis antigens, seven donors were positive for only a single allotype, and three were positive for two allotypes in an individual. However, only one allotype was used for a single antigen-specific response when a single tuberculosis antigen was used individually. These results on the distribution of HLA class II allotypes showing high CD4 T-cell responses to antigens and the intra-individual allotype dominance will provide valuable information for understanding the immunobiology and immunogenetics of tuberculosis, which can contribute to the development of more effective vaccines.
感染通常无症状,如同潜伏性肺结核,但它仍然是世界上主要的细菌致死原因。潜伏性肺结核感染的诊断依赖于对分枝杆菌抗原的细胞免疫证据。由于已经在几个人群中报告了 HLA Ⅱ类与肺结核感染之间的关联,因此需要对主要结核抗原的 CD4 T 细胞反应进行详细研究。为了阐明个体中哪些 HLA Ⅱ类同种异型优先用于肺结核,全面分析了 TB10.4、Ag85b、ESAT-6 和 CFP-10 抗原的 CD4 T 细胞反应。通过分析表达单个 HLA Ⅱ类同种异型的人工抗原呈递细胞的面板,使用 和培养 ELISPOT 分析了 33 名健康供体。与 ELISPOT 相比,培养的 ELISPOT 中 CD4 T 细胞反应平均增加了 39 倍。在 和培养的 ELISPOT 中,CD4 T 细胞反应与 HLA-DQ 和 HLA-DP 基因座相比,HLA-DR 显著更高。在培养的 ELISPOT 中,9 个 HLA-DR 同种异型、4 个 HLA-DQ 同种异型和 3 个 HLA-DP 同种异型显示出阳性的 CD4 T 细胞反应。在对混合结核分枝杆菌抗原进行测试时,有 10 名供体的 CD4 T 细胞反应呈阳性,其中 7 名供体仅对单个同种异型呈阳性,而 3 名供体在个体中对两种同种异型呈阳性。然而,当单独使用单个结核抗原时,仅使用单个同种异型进行单个抗原特异性反应。这些关于显示对 抗原具有高 CD4 T 细胞反应的 HLA Ⅱ类同种异型的分布和个体内同种异型优势的结果将为理解肺结核的免疫生物学和免疫遗传学提供有价值的信息,这有助于开发更有效的疫苗。